Instylla Revenue and Competitors

Location

$64M

Total Funding

Estimated Revenue & Valuation

  • Instylla's estimated annual revenue is currently $13.6M per year.(i)
  • Instylla's estimated revenue per employee is $251,000
  • Instylla's total funding is $64M.

Employee Data

  • Instylla has 54 Employees.(i)
  • Instylla grew their employee count by -2% last year.

Instylla's People

NameTitleEmail/Phone
1
VP Research & Development and OperationsReveal Email/Phone
2
VP Research & Development and OperationsReveal Email/Phone
3
VP Quality and RegulatoryReveal Email/Phone
4
Sr. Director Program Management & Materials PlanningReveal Email/Phone
5
Director MarketingReveal Email/Phone
6
Senior Director Business OperationsReveal Email/Phone
7
Senior Clinical Field ManagerReveal Email/Phone
8
Manager Clinical AffairsReveal Email/Phone
9
Clinical Field Support ManagerReveal Email/Phone
10
Sr. Clinical Field ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.1M49-18%$10MN/A
#2
$30.4M12129%N/AN/A
#3
$139.8M913-3%$200KN/A
#4
$84.1M0N/A$1.2MN/A
#5
$43.4M17330%N/AN/A
#6
$64.5M25712%N/AN/A
#7
$64.3M20526%$129.6MN/A
#8
$19.6M78-7%N/AN/A
#9
$65.8M2627%N/AN/A
#10
$73.7M23520%$115.5MN/A
Add Company

What Is Instylla?

keywords:N/A

$64M

Total Funding

54

Number of Employees

$13.6M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Instylla News

2022-03-30 - Intrahepatic Cholangiocarcinoma Clinical Trial Pipeline ...

... Siranomics, Instylla, Inc. and others are currently working to improve the Intrahepatic Cholangiocarcinoma treatment landscape.

2022-03-22 - Instylla First-In-Human Clinical Trial Published Results ...

Instylla, Inc., a privately held company developing next-generation liquid embolics for. Figure 1: Before and after embolization images for...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.9M540%N/A
#2
$7.6M54-2%N/A
#3
$13.1M54-17%N/A
#4
$12M540%N/A
#5
$12.2M5415%N/A